Foxy-5
Foxy-5 has been used in trials studying the treatment of Prostate Cancer, Colorectal Cancer, Metastatic Colon Cancer, Metastatic Breast Cancer, and Metastatic Prostate Cancer.
Online Inquiry
| CAT# | R1861 |
| CAS | 881188-51-8 |
| M.F/Formula | C26H42N6O12S2 |
| M.W/Mr. | 694.8 |
| Sequence | One Letter Code: MDGCEL (Modifications: Met-1 = N-Formyl)
Three Letter Code: Met-Asp-Gly-Cys-Glu-Leu |
| Purity | > 95% |
| Activity | Wnt5a peptide mimetic. Impairs migration and invasion of 4T1 breast cancer cells in vitro. Also inhibits metastasis of inoculated 4T1 cells in mice. |
| Source# | Synthetic |
Storage | Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date. |
Solubility | Soluble to 1 mg/ml in PBS (pH 7.4); 10 mM in DMSO |
Shipping Condition | Wet ice in continental US; may vary elsewhere |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
